T2Candida Diagnostic Test for ICU Patients at Risk for Invasive Candidiasis
The combination of the new test T2Candida and blood culture seemed to have the best performance in the detection of invasive candidiasis.
Diagnostic Testing
HPV16 Antibodies Can Develop Long Before Throat Cancer Diagnosis
Seroconversion to human papillomavirus type 16 -E6 antibody positivity can occur decades before diagnosis of oropharyngeal squamous cell carcinoma.
Fibronectin Predicts Seroclearance in Chronic Hepatitis B
Fibronectin may be a potential marker for hepatitis B surface antigen seroclearance.
Gonorrhea Test ResistancePlus GC Granted Breakthrough Device Status
The FDA has granted Breakthrough Device designation to ResistancePlus GC,, a test that detects ciprofloxacin susceptibility.
Mouth Rinse for HPV DNA May Be Biomarker in Head, Neck Cancer
Persistent detection of tumor-type HPV DNA during treatment tied to increased risk for recurrence, death
PPD Shortage Prompts CDC to Issue New Recommendations for TB Testing
The CDC announced an expected 3 to 10 month shortage of Aplisol (tuberculin purified protein derivative [PPD], diluted), used as an aid in the diagnosis of tuberculosis.
Point-of-Care Testing Improves Management for Urogenital Infection in Women
Point-of-care testing may improve infection management in women with urogenital infection, according to a study published in Lancet Infectious Diseases. With an estimated 357 million new curable infections caused by Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Treponema pallidum occuring in 2012, sexually transmitted infections and other urogenital infections are a major disease burden worldwide.…
T2Bacteria Panel Detects and Identifies Bloodstream Infections
Bloodstream infections can be accurately distinguished or excluded within a 4- to 8-hour timeframe using the T2Bacteria Panel.
FDA Clears Tests for Chlamydia, Gonorrhea Using Extragenital Samples
The FDA has cleared the Aptima Combo 2 Assay (Hologic) and the Xpert CT/NG (Cepheid) to detect chlamydia and gonorrhea via throat and rectum samples.
Latent TB Detection: QuantiFERON-TB Gold Plus vs QuantiFERON-TB Gold In-Tube
Positive results with respect to the presence of latent tuberculosis infection in patients with renal failure were more consistent with the use of QuantiFERON-TB Gold Plus testing compared with the use of QuantiFERON-TB Gold In-Tube testing.
Next post in Diagnostics
